ArticleFrontiers in pharmacology2022

Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis.

Mengying Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.